Evolent Health (EVH) Reports Q2 Loss, Misses Revenue Estimates

Company Performance - Evolent Health reported a quarterly loss of $0.1 per share, missing the Zacks Consensus Estimate of $0.09, and down from earnings of $0.3 per share a year ago, representing an earnings surprise of -211.11% [1] - The company posted revenues of $444.33 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 2.86%, and down from $647.15 million year-over-year [2] - Evolent Health has not surpassed consensus EPS estimates over the last four quarters and has topped consensus revenue estimates only once during the same period [2] Stock Performance - Evolent Health shares have declined approximately 16.4% since the beginning of the year, contrasting with the S&P 500's gain of 7.9% [3] - The current Zacks Rank for Evolent Health is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.12 on revenues of $539.68 million, and for the current fiscal year, it is $0.40 on revenues of $2.06 billion [7] - The outlook for the Medical Info Systems industry, where Evolent Health operates, is currently in the top 37% of Zacks industries, suggesting a favorable environment for stock performance [8]